chr5-1283197-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_198253.3(TERT):​c.1574-573T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.56 ( 17427 hom., cov: 18)

Consequence

TERT
NM_198253.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.98

Publications

10 publications found
Variant links:
Genes affected
TERT (HGNC:11730): (telomerase reverse transcriptase) Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008]
TERT Gene-Disease associations (from GenCC):
  • pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • dyskeratosis congenita, autosomal dominant 2
    Inheritance: AR, AD, SD, Unknown Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Laboratory for Molecular Medicine
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • dyskeratosis congenita
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hoyeraal-Hreidarsson syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • melanoma, cutaneous malignant, susceptibility to, 9
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.64 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TERTNM_198253.3 linkc.1574-573T>C intron_variant Intron 2 of 15 ENST00000310581.10 NP_937983.2 O14746-1
TERTNM_001193376.3 linkc.1574-573T>C intron_variant Intron 2 of 14 NP_001180305.1 O14746-3
TERTNR_149162.3 linkn.1653-573T>C intron_variant Intron 2 of 12
TERTNR_149163.3 linkn.1653-573T>C intron_variant Intron 2 of 12

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TERTENST00000310581.10 linkc.1574-573T>C intron_variant Intron 2 of 15 1 NM_198253.3 ENSP00000309572.5 O14746-1

Frequencies

GnomAD3 genomes
AF:
0.564
AC:
65401
AN:
116008
Hom.:
17407
Cov.:
18
show subpopulations
Gnomad AFR
AF:
0.576
Gnomad AMI
AF:
0.556
Gnomad AMR
AF:
0.651
Gnomad ASJ
AF:
0.522
Gnomad EAS
AF:
0.631
Gnomad SAS
AF:
0.524
Gnomad FIN
AF:
0.549
Gnomad MID
AF:
0.439
Gnomad NFE
AF:
0.541
Gnomad OTH
AF:
0.550
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.564
AC:
65447
AN:
116078
Hom.:
17427
Cov.:
18
AF XY:
0.568
AC XY:
31919
AN XY:
56158
show subpopulations
African (AFR)
AF:
0.576
AC:
17006
AN:
29526
American (AMR)
AF:
0.652
AC:
7932
AN:
12170
Ashkenazi Jewish (ASJ)
AF:
0.522
AC:
1540
AN:
2948
East Asian (EAS)
AF:
0.632
AC:
2201
AN:
3484
South Asian (SAS)
AF:
0.525
AC:
1743
AN:
3320
European-Finnish (FIN)
AF:
0.549
AC:
3672
AN:
6690
Middle Eastern (MID)
AF:
0.443
AC:
54
AN:
122
European-Non Finnish (NFE)
AF:
0.541
AC:
30062
AN:
55570
Other (OTH)
AF:
0.548
AC:
897
AN:
1636
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
1347
2694
4042
5389
6736
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
538
1076
1614
2152
2690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0651
Hom.:
42

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
1.9
DANN
Benign
0.20
PhyloP100
-3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7713218; hg19: chr5-1283312; API